Eli Lilly

Topics • Technology

Genzyme Names Ex-Lilly Exec to Head Manufacturing

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Interview

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

CONTINUUS Pharmaceuticals, Inc.

DCAT - Drug, Chemical & Associated Technologies Association

Frost & Sullivan

Microinnova Engineering GmbH

Hovione

Eli Lilly and Company

Sanofi S.A.

Camelot Management Consultants AG

SchüllerConsulting

Bayer AG

Oracle Germany

GlaxoSmithKline (GSK) plc

Lilly Deutschland GmbH

GlobalData

Isomorphic Labs

IEDC Europe Indiana

Fitch Ratings

KPMG

Eli Lilly

Roche Gives Up on Heart Drug after Trial Disappoints

Amgen to Buy Turkish Drugmaker for $700 mln

Piramal Sees $1.5 Billion Revenue from Potential Alzheimer's Drug

Icahn Sues Amylin, Pushes for Sale

Amylin Rejected $3.5 bln Bristol Offer

Hovione Announces Appointment of Colin Minchom as Vice President, Particle Design Business Unit

Colin Minchom Appointed VP Particle Design BU at Hovione

Bayer Sounds Out Debt Market with Eye On Deals

Indiana’s Government Caters to Businesses

Lilly Working to Increase Enrollment of Diverse Populations in Clinical Trials

EU Clears Eli Lilly To Buy J&J Animal Health Unit

Amylin Sues Lilly over Diabetes Partnership

Roche Seen Kicking off Q1 Season With Sales Drop

British Man Jailed After Record Fake Medicine Bust

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

Patent Cliff To Intensify in the U.S. in 2011

Eli Lilly, Boehringer Ingelheim in Drug-Development Alliance

Bristol-Myers, Lilly Win Major Drug Patent Rulings

White Knight Could Be Elusive For Genzyme

Big Pharma Stocks Could Rally in the Next Year

Pfizer Selling China Swine Vaccine Unit to Harbin Pharma

Merck Health-reform Costs Below Rivals

Novartis Sticks To FY Goals As Q1 EPS Beats Forecast

Eli Lilly to Launch 15 New Products in China in 5 Years

Bayer Still Out To Buy, Not Sell, Vet Businesses

Genzyme Says FDA Takes Enforcement Action At Plant

Genzyme Names Ex-Lilly Exec to Head Manufacturing

Top-Feature

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Interview

Navigating Uncertainty and Driving Innovation

Eli Lilly

Top-Feature

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Interview

Newsletter & e-edition